LEONI, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 487
EU - Europa 184
AS - Asia 61
Continente sconosciuto - Info sul continente non disponibili 2
Totale 734
Nazione #
US - Stati Uniti d'America 480
SE - Svezia 44
IT - Italia 35
CN - Cina 32
DE - Germania 27
IE - Irlanda 22
VN - Vietnam 13
DK - Danimarca 11
GB - Regno Unito 10
UA - Ucraina 7
CA - Canada 6
FR - Francia 6
BE - Belgio 5
RU - Federazione Russa 5
FI - Finlandia 4
SG - Singapore 4
TR - Turchia 4
AT - Austria 3
CZ - Repubblica Ceca 2
EU - Europa 2
HK - Hong Kong 2
ID - Indonesia 2
IN - India 2
NL - Olanda 2
JP - Giappone 1
KR - Corea 1
MX - Messico 1
PL - Polonia 1
Totale 734
Città #
Ann Arbor 137
Fairfield 53
Wilmington 44
Chandler 37
Woodbridge 29
Cambridge 23
Dublin 22
Ashburn 21
Dearborn 21
Frankfurt am Main 20
Seattle 16
Houston 14
New York 14
Nanjing 10
Princeton 10
Dong Ket 9
Jacksonville 9
Milan 9
Lawrence 5
Brussels 4
Grafing 4
Guangzhou 4
Rome 4
Altamura 3
Hangzhou 3
Helsinki 3
Kunming 3
Shanghai 3
Vienna 3
Boardman 2
Bonndorf 2
Brno 2
Edmonton 2
Fort Worth 2
Fuzhou 2
Hong Kong 2
Istanbul 2
Jakarta 2
Lissone 2
Merate 2
San Diego 2
Shenyang 2
Singapore 2
Stockholm 2
Toronto 2
Ancona 1
Andover 1
Auma 1
Bloomingdale 1
Bloomsbury 1
Brendola 1
Brussel 1
Changsha 1
Chicago 1
Cuajimalpa 1
Desio 1
Edinburgh 1
Hefei 1
Jinan 1
Kraków 1
Kwangju 1
Lachine 1
Loreto 1
Mountain View 1
Nanchang 1
Ottawa 1
Paris 1
Sassari 1
Stony Brook 1
Sulmona 1
Taizhou 1
Turin 1
Valdagno 1
Totale 597
Nome #
Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies 260
Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: High white blood cell count at diagnosis is the strongest prognostic factor 171
Tyrosine kinase inhibitors in BCR-ABL positive acute lymphoblastic leukemia 124
Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial 119
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols 117
Totale 791
Categoria #
all - tutte 2.452
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.452


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020189 17 8 12 15 16 22 21 19 19 22 13 5
2020/2021193 7 11 18 15 9 20 23 29 14 13 10 24
2021/202273 5 8 11 3 4 9 6 4 5 1 7 10
2022/2023132 15 49 6 13 6 19 1 12 6 0 4 1
2023/202466 1 3 2 6 8 18 15 4 2 0 0 7
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 791